Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034, and By Region

Description

List of Tables

The peripheral artery disease (PAD) market size is expected to reach USD 10.53 billion by 2034, according to a new study by Polaris Market Research. The report "Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034," gives a detailed insight into current market dynamics and provides analysis on future market growth.

The peripheral artery disease (PAD) market focuses on the diagnosis, treatment, and management of atherosclerotic blockages in the peripheral arteries, primarily affecting the lower extremities. This condition leads to reduced blood flow, causing pain, tissue damage, and in severe cases, limb amputation. The increasing prevalence of risk factors such as diabetes, hypertension, smoking, and obesity is expanding the target population and fueling demand for effective PAD therapies. Advancements in vascular imaging and early diagnostic tools are improving detection rates, while the shift toward minimally invasive procedures is driving preference for endovascular treatments over traditional surgery. Technological progress in drug-eluting stents, balloon angioplasty, and atherectomy systems is enhancing patient outcomes and procedural efficiency. Market growth is further supported by the development of combination therapies and personalized treatment approaches tailored to disease severity and patient comorbidities.

The integration of digital health platforms into vascular care is enabling remote monitoring, treatment adherence, and data-driven interventions. Strong investments in research and clinical trials continue to shape innovation, particularly in anti-restenosis devices and bioresorbable implants. Strategic collaborations among healthcare providers, medtech firms, and research institutions are fostering the commercialization of advanced PAD solutions. In addition, increasing awareness campaigns and screening initiatives are encouraging earlier intervention, thus expanding the addressable market. Growing emphasis on value-based care and patient-centric treatment models is reinforcing the importance of cost-effective and outcome-driven PAD therapies. The market remains competitive and innovation-driven, presenting substantial opportunities for stakeholders committed to addressing unmet needs in peripheral vascular disease management.

Peripheral Artery Disease Market Report Highlights

By treatment type, the device segment accounted for ~62% of the revenue share in 2024, due to the wider adoption of stents, angioplasty balloons, and atherectomy devices for minimally invasive procedures is contributing to strong demand in the device segment.

Based on distribution channel, the hospital pharmacy segment accounted for the largest revenue share in 2024 due to the high patient inflow for complex PAD interventions, such as angioplasty or bypass surgeries, contributes to the dominance of hospital pharmacies.

Asia Pacific is expected to grow significantly from 2025 to 2034 due to rapidly expanding healthcare systems, rising disposable income, and growing health awareness are contributing to improved PAD screening and diagnosis rates.

The North America peripheral artery disease market accounted for the largest revenue share in 2024 due to the high prevalence of cardiovascular risk factors, such as diabetes, obesity, and smoking, has increased the burden of peripheral artery disease across the region.

A few global key players include Amedisys, Inc.; B. Braun SE; Baxter; BD; CareCentrix, Inc.; Coram LLC.; Fresenius Kabi AG; ICU Medical, Inc.; JMS Co. Ltd.; Moog Inc.; Option Care Health, Inc.; PharMerica Corporation; and Terumo Corporation.

Polaris Market Research has segmented the peripheral artery disease market report on the basis of treatment type, distribution channel, end user, and region:

By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)

Device

Balloon Catheters

Plaque Modification Devices

Stents

Atherectomy Devices

Guidewires and Sheaths

Other Devices

Drug Type

Lipid-lowering Drugs

Antiplatelet Drugs

Thrombolytic Agents

Triple-H Therapy

Other Drugs

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacy

Retail Pharmacy

Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospital

Specialty Clinics

Ambulatory Surgical Centers

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Product Code: PM6022

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Peripheral Artery Disease Market Insights

4.1. Peripheral Artery Disease Market - Market Snapshot
4.2. Peripheral Artery Disease Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Diabetes and Hypertension
  - 4.2.1.2. Aging Global Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High treatment costs.
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Peripheral Artery Disease Market Trends
4.6. Value Chain Analysis

5. Global Peripheral Artery Disease Market, by Treatment Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
5.3. Device
- 5.3.1. Global Peripheral Artery Disease Market, by Device, by Region, 2020-2034 (USD Billion)
- 5.3.2. Balloon Catheters
  - 5.3.2.1. Global Peripheral Artery Disease Market, by Balloon Catheters, 2020-2034 (USD Billion)
- 5.3.3. Plaque Modification Devices
  - 5.3.3.1. Global Peripheral Artery Disease Market, by Plaque Modification Devices, by Region, 2020-2034 (USD Billion)
- 5.3.4. Stents
  - 5.3.4.1. Global Peripheral Artery Disease Market, by Stents, 2020-2034 (USD Billion)
- 5.3.5. Atherectomy Devices
  - 5.3.5.1. Global Peripheral Artery Disease Market, by Atherectomy Devices, by Region, 2020-2034 (USD Billion)
- 5.3.6. Guidewires and Sheaths
  - 5.3.6.1. Global Peripheral Artery Disease Market, by Guidewires and Sheaths, 2020-2034 (USD Billion)
- 5.3.7. Other Devices
  - 5.3.7.1. Global Peripheral Artery Disease Market, by Other Devices, by Region, 2020-2034 (USD Billion)
5.4. Drug Type
- 5.4.1. Global Peripheral Artery Disease Market, by Drug Type, by Region, 2020-2034 (USD Billion)
- 5.4.2. Lipid-lowering Drugs
  - 5.4.2.1. Global Peripheral Artery Disease Market, by Lipid-lowering Drugs, 2020-2034 (USD Billion)
- 5.4.3. Antiplatelet Drugs
  - 5.4.3.1. Global Peripheral Artery Disease Market, by Antiplatelet Drugs, by Region, 2020-2034 (USD Billion)
- 5.4.4. Thrombolytic Agents
  - 5.4.4.1. Global Peripheral Artery Disease Market, by Thrombolytic Agents, 2020-2034 (USD Billion)
- 5.4.5. Triple-H Therapy
  - 5.4.5.1. Global Peripheral Artery Disease Market, by Triple-H Therapy, by Region, 2020-2034 (USD Billion)
- 5.4.6. Other Drugs
  - 5.4.6.1. Global Peripheral Artery Disease Market, by Other Drugs, 2020-2034 (USD Billion)

6. Global Peripheral Artery Disease Market, by Distribution Channel

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
6.3. Hospital Pharmacy
- 6.3.1. Global Peripheral Artery Disease Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
6.4. Retail Pharmacy
- 6.4.1. Global Peripheral Artery Disease Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
6.5. Others
- 6.5.1. Global Peripheral Artery Disease Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Peripheral Artery Disease Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
7.3. Hospital
- 7.3.1. Global Peripheral Artery Disease Market, by Hospital, by Region, 2020-2034 (USD Billion)
7.4. Specialty Clinics
- 7.4.1. Global Peripheral Artery Disease Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
7.5. Ambulatory Surgical Centers
- 7.5.1. Global Peripheral Artery Disease Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)

8. Global Peripheral Artery Disease Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Peripheral Artery Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Peripheral Artery Disease Market - North America
- 8.3.1. North America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.3. North America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Peripheral Artery Disease Market - U.S.
  - 8.3.4.1. U.S.: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Peripheral Artery Disease Market - Canada
  - 8.3.5.1. Canada: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
8.4. Peripheral Artery Disease Market - Europe
- 8.4.1. Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.3. Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Peripheral Artery Disease Market - UK
  - 8.4.4.1. UK: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Peripheral Artery Disease Market - France
  - 8.4.5.1. France: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Peripheral Artery Disease Market - Germany
  - 8.4.6.1. Germany: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Peripheral Artery Disease Market - Italy
  - 8.4.7.1. Italy: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Peripheral Artery Disease Market - Spain
  - 8.4.8.1. Spain: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Peripheral Artery Disease Market - Netherlands
  - 8.4.9.1. Netherlands: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Peripheral Artery Disease Market - Russia
  - 8.4.10.1. Russia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Peripheral Artery Disease Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
8.5. Peripheral Artery Disease Market - Asia Pacific
- 8.5.1. Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Peripheral Artery Disease Market - China
  - 8.5.4.1. China: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Peripheral Artery Disease Market - India
  - 8.5.5.1. India: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Peripheral Artery Disease Market - Malaysia
  - 8.5.6.1. Malaysia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Peripheral Artery Disease Market - Japan
  - 8.5.7.1. Japan: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Peripheral Artery Disease Market - Indonesia
  - 8.5.8.1. Indonesia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Peripheral Artery Disease Market - South Korea
  - 8.5.9.1. South Korea: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Peripheral Artery Disease Market - Australia
  - 8.5.10.1. Australia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Peripheral Artery Disease Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
8.6. Peripheral Artery Disease Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Peripheral Artery Disease Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Peripheral Artery Disease Market - UAE
  - 8.6.5.1. UAE: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Peripheral Artery Disease Market - Israel
  - 8.6.6.1. Israel: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Peripheral Artery Disease Market - South Africa
  - 8.6.7.1. South Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Peripheral Artery Disease Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
8.7. Peripheral Artery Disease Market - Latin America
- 8.7.1. Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Peripheral Artery Disease Market - Mexico
  - 8.7.4.1. Mexico: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Peripheral Artery Disease Market - Brazil
  - 8.7.5.1. Brazil: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Peripheral Artery Disease Market - Argentina
  - 8.7.6.1. Argentina: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Peripheral Artery Disease Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. AngioDynamics
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. B. Braun SE
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Bayer AG
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. BD
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Biotronik
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Boston Scientific Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Cardinal Health
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Endologix LLC
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. iVascular
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Johnson & Johnson
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Koninklijke Philips N.V.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Medtronic
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Terumo Corporation
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development